Bacteroides

Revision as of 16:54, 8 August 2015 by Ammu Susheela (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Bacteroides
Bacteroides spp. anaerobically cultured in blood agar medium.
Bacteroides spp. anaerobically cultured in blood agar medium.
Scientific classification
Kingdom: Bacteria
Phylum: Bacteroidetes
Class: Bacteroidetes
Order: Bacteroidales
Family: Bacteroidaceae
Genus: Bacteroides
Castellani & Chalmers 1919
Species

B. acidifaciens
B. distasonis (reclassified as Parabacteroides distasonis)
B. gracilis
B. fragilis
B. oris
B. ovatus
B. putredinis
B. pyogenes
B. stercoris
B. suis
B. tectus
B. thetaiotaomicron
B. vulgatus
etc.

Overview

Bacteroides is a genus of Gram-negative, rod-shaped bacteria. Bacteroides species are non-endospore-forming, anaerobes, and may either be motile or non-motile, depending on the species.[1] The DNA base composition is 40-48% GC. Unusual in bacterial organisms, Bacteroides membranes contain sphingolipids. They also contain meso-diaminopimelic acid in their peptidoglycan layer.

Bacteroides are normally commensal, making up the most substantial portion of the mammalian gastrointestinal flora,[2] where they play a fundamental role in processing of complex molecules to simpler ones in the host intestine. As many as 1010-1011 cells per gram of human feces have been reported.[3] They can use simple sugars when available, but the main source of energy is polysaccharides from plant sources.

Pathogenesis

Bacteroides species also benefit their host by excluding potential pathogens from colonizing the gut. Some species (B. fragilis, for example) are opportunistic human pathogens, causing infections of the peritoneal cavity, gastrointestinal surgery, and appendicitis via abscess formation, inhibiting phagocytosis, and inactivating beta-lactam antibiotics.[4] Although Bacteroides species are anaerobic, they are aerotolerant and thus can survive in the abdominal cavity.

Bacteroides are generally resistant to a wide variety of antibiotics — beta-lactams, aminoglycosides, and recently many species have acquired resistance to erythromycin and tetracycline. This high level of antibiotic resistance has prompted concerns that Bacteroides species may become a reservoir for resistance in other, more highly pathogenic bacterial strains.[5]

B. fragilis

Bacteroides fragilis is an obligate anaerobe of the gut. It is involved in 90% of anaerobic peritoneal infections. B. fragilis is generally susceptible to metronidazole, carbapenems, and beta-lactam/beta-lactamase inhibitor combinations (e.g., Unasyn, Zosyn). The bacteria has inherent high-level resistance to penicillin. Clindamycin is no longer recommended as the first-line agent for B. fragilis due to emerging high-level resistance (>30% in some reports).[6]

Treatment

Antimicrobial regimen

  • 1. Monotherapy
  • Preferred regimen (4): Doripenem 0.5-1.0 g IV q6h
  • Preferred regimen (7): Tigecycline 100 mg IV THEN 50 mg IV q12h
  • 2. Combination therapy

Gallery


References

  1. Madigan M, Martinko J (editors). (2005). Brock Biology of Microorganisms (11th ed. ed.). Prentice Hall. ISBN 0-13-144329-1.
  2. Dorland WAN (editor) (2003). Dorland's Illustrated Medical Dictionary (30th ed.). W.B. Saunders. ISBN 0-7216-0146-4.
  3. Finegold SM, Sutter VL, Mathisen GE (1983). Normal indigenous intestinal flora (pp. 3-31) in Human intestinal microflora in health and disease. Academic Press. ISBN 0-12-341280-3.
  4. Ryan KJ, Ray CG (editors) (2004). Sherris Medical Microbiology (4th ed. ed.). McGraw Hill. ISBN 0-8385-8529-9.
  5. Salyers AA, Gupta A, Wang Y (2004). "Human intestinal bacteria as reservoirs for antibiotic resistance genes". Trends Microbiol. 12 (9): 412–6. ISSN 0966-842X. PMID 15337162.
  6. Mandell GL, Bennett JE, Dolin R (2004). Principles and Practice of Infectious Diseases (6th ed. ed.). Churchill Livingstone. ISBN 0443066434.
  7. Bartlett, John (2012). Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases. Burlington, MA: Jones and Bartlett Learning. ISBN 978-1449625580.
  8. 8.00 8.01 8.02 8.03 8.04 8.05 8.06 8.07 8.08 8.09 8.10 8.11 8.12 8.13 8.14 8.15 8.16 8.17 8.18 8.19 8.20 8.21 8.22 8.23 8.24 8.25 8.26 8.27 8.28 8.29 "Public Health Image Library (PHIL)".

See also

External links

Template:WikiDoc Sources Template:Jb1